Literature DB >> 18415812

COPD as a systemic disease.

Alvar Agusti1, Joan B Soriano.   

Abstract

Chronic obstructive pulmonary disease (COPD) represents an important and increasing burden throughout the world. Classically, COPD has been considered a respiratory condition only, mainly caused by tobacco smoking. However, COPD has important manifestations beyond the lungs, the so-called systemic effects. These include unintentional weight loss, skeletal muscle dysfunction, an increased risk of cardiovascular disease, osteoporosis, and depression, among others. Low-grade, chronic systemic inflammation is one of the key mechanisms underlying these systemic effects. Because these extra-pulmonary manifestations of COPD are common and/or may have significant implications for the patient wellbeing and prognosis, they warrant systematic screening and appropriate management in order to provide optimal medical care.

Entities:  

Mesh:

Year:  2008        PMID: 18415812     DOI: 10.1080/15412550801941349

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  63 in total

1.  A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Daniel E Fenker; Cameron T McDaniel; Warunya Panmanee; Ralph J Panos; Eric J Sorscher; Carleen Sabusap; John P Clancy; Daniel J Hassett
Journal:  Int J Respir Pulm Med       Date:  2018-11-29

2.  Monocyte chemoattractant protein-1 released from alveolar macrophages mediates the systemic inflammation of acute alveolar hypoxia.

Authors:  Jie Chao; Paula Donham; Nico van Rooijen; John G Wood; Norberto C Gonzalez
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-02       Impact factor: 6.914

3.  Improved health-related quality of life after lung volume reduction surgery and pulmonary rehabilitation.

Authors:  Janna Beling
Journal:  Cardiopulm Phys Ther J       Date:  2009-09

4.  Chronic obstructive pulmonary disease and the risk of cardiovascular diseases.

Authors:  Cornelia Schneider; Ulrich Bothner; Susan S Jick; Christoph R Meier
Journal:  Eur J Epidemiol       Date:  2010-02-27       Impact factor: 8.082

5.  Omics and the Search for Blood Biomarkers in Chronic Obstructive Pulmonary Disease. Insights from COPDGene.

Authors:  Elizabeth A Regan; Craig P Hersh; Peter J Castaldi; Dawn L DeMeo; Edwin K Silverman; James D Crapo; Russell P Bowler
Journal:  Am J Respir Cell Mol Biol       Date:  2019-08       Impact factor: 6.914

Review 6.  Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

Authors:  Daniel J Hassett; Michael T Borchers; Ralph J Panos
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

Review 7.  Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.

Authors:  Joanna L Richens; Richard A Urbanowicz; Elizabeth A M Lunt; Rebecca Metcalf; Jonathan Corne; Lucy Fairclough; Paul O'Shea
Journal:  Respir Res       Date:  2009-04-22

8.  Chronic obstructive pulmonary disease patients have greater systemic responsiveness to ex vivo stimulation with swine dust extract and its components versus healthy volunteers.

Authors:  Janel R Harting; Angela Gleason; Debra J Romberger; Susanna G Von Essen; Fang Qiu; Neil Alexis; Jill A Poole
Journal:  J Toxicol Environ Health A       Date:  2012

9.  Altered effector function of peripheral cytotoxic cells in COPD.

Authors:  Richard A Urbanowicz; Jonathan R Lamb; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  Respir Res       Date:  2009-06-22

Review 10.  Long-term therapy in COPD: any evidence of adverse effect on bone?

Authors:  Arnulf Langhammer; Siri Forsmo; Unni Syversen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.